Sarah Schram

Stock Analyst at William Blair

(0.61)

# 3,699

Out of 4,829 analysts

Total ratings

50%

Success rate

-14.57%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sarah Schram

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	DNLI Denali Therapeutics	Initiates: Outperform	n/a	$14.80	-	1	Jan 3, 2025
	VIGL Vigil Neuroscience	Initiates: Outperform	n/a	$2.53	-	1	Dec 4, 2024

Denali Therapeutics

Jan 3, 2025

Initiates: Outperform

Price Target: n/a

Current: $14.80

Upside: -

Vigil Neuroscience

Dec 4, 2024

Initiates: Outperform

Price Target: n/a

Current: $2.53

Upside: -